# X-Bolt Orthopaedics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/x-bolt-orthopaedics

- Industry: Medical Devices & Equipment
- Headquarters: Dublin, Ireland
- Website: www.x-bolt.com
- Total disclosed funding: $2.4M
- Latest round: Seed (Jan 17, 2014)
- Investors on record: 1

## About

X-Bolt Orthopaedics develops advanced surgical solutions for hip fracture fixation, focusing on innovative products that enhance surgical efficiency and patient outcomes.Founded in 2007 in Dublin, Ireland, X-Bolt Orthopaedics specializes in the design and manufacture of surgical devices for hip fracture management. The company, led by CEO Brian Thornes, recently raised EUR 3.26 million in funding on October 20, 2023, aimed at further commercializing its Pro-X1 product. The firm has completed two deals to date, with a total amount raised of EUR 3.26 million, resulting in a current valuation of EUR 17.92 million.X-Bolt Orthopaedics specializes in innovative surgical solutions for hip fracture fixation, with its flagship product being the Pro-X1 Trochanteric Nail. This product is designed to compact surrounding bone for enhanced anchorage, particularly in unstable A2 and A3 fractures. The Pro-X1 Troch Nail provides biomechanical advantages including rotational stability and minimal bone disruption, effectively meeting the surgical requirements of orthopedic surgeons. Targeted end users include hospitals, surgeons, and healthcare providers in multiple geographical markets, including North America and Europe. The company emphasizes its commitment to improving patient outcomes through faster surgeries and reduced hospital stays, addressing critical needs within the orthopedic field.X-Bolt Orthopaedics generates revenue through direct sales of its Pro-X1 Trochanteric Nail and related surgical instrumentation to hospitals and surgical centers. The transaction structure primarily operates on a B2B model, where healthcare institutions purchase products directly from the company or through established distributors. These sales transactions are typically facilitated by established contracts or purchasing agreements, allowing for bulk order discounts. The company's pricing strategy is structured around the specific needs of surgical facilities and the complexity of the procedures involved, ensuring competitive pricing for its advanced orthopedic solutions. X-Bolt's focus on providing value through superior clinical outcomes further solidifies its standing in the orthopedic medical device market.In October 2023, X-Bolt Orthopaedics raised EUR 3.26 million in venture funding led by Business Venture Partners, with participation from HBAN Angel Network, Amalfi Capital Management, and Ascentifi Limited. This funding will be utilized to commercialize its Pro-X1 product, aligning with the company's strategy to enhance its market presence. X-Bolt Orthopaedics plans to introduce new products in the coming years and expand its reach into additional markets in North America and Europe.

## Funding rounds

- Seed, Jan 17, 2014, $2.4M — Furthr

## Investors

- Furthr (https://capitalatlas.ai/funds/furthr) — Seed